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Abstract Physiological levels of nitric oxide (NO) regulate
vascular tone and protect the microvasculature from injury
whereas excessive NO may be harmful. The present study
explored the effects of NO on human endothelial cell apoptosis.
We found that the NO donor S-nitroso-N-acetylpenicillamine
(SNAP) inhibited TNFK-induced endothelial apoptosis and that
this was mediated partly through the cGMP pathway. In
contrast, high SNAP concentration induced endothelial apoptosis
via cGMP-independent pathways and the cGMP pathway
protected against NO-induced apoptosis. These findings demon-
strate that low NO concentrations contribute to human
endothelial cell survival, whereas higher NO concentrations are
pathological and promote destruction of endothelial cells.
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1. Introduction
The endothelium provides an anti-thrombotic and anti-in-
£ammatory barrier for the normal blood-vascular wall inter-
face. Intact endothelium also acts as a sensor and transducer
of signals that regulate physiological functions of vascular
wall. Dysfunction of endothelial cells has been shown to pro-
mote atherogenesis. However, mechanisms maintaining the
integrity of the endothelium are unclear. Endothelial apopto-
sis is a physiological process which contributes to vessel ho-
meostasis by eliminating damaged cells from the vessel wall ; if
increased it may lead to disturbed endothelial function and
this may promote atherogenesis. It has been demonstrated
that endothelial cell damage plays an important role in the
progression of glomerular sclerosis [1^3] and in acute tubular
necrosis occurring in the generalised Shwartzman reaction [4].
Endothelial cell damage also occurs during hypertension-in-
duced microvascular rarefaction [5] and septic shock [6]. In
addition, regions of atherosclerotic lesions are characterised
by an enhanced endothelial cell ‘turnover’ [7], which could
be due to increased endothelial cell apoptosis. These ¢ndings
suggest a possible link between endothelial cell apoptosis and
atherosclerosis. Although a causative role for apoptosis in
atherogenesis remains hypothetical, it has been shown that
apoptotic endothelial cells up-regulate the expression of inter-
cellular adhesion molecules on normal endothelial cells result-
ing in hyperadhesiveness [8].
Nitric oxide (NO) is a free radical synthesised from L-argi-
nine by NO synthases (NOS). Three isoforms of NOS (neuro-
nal (nNOS), endothelial NOS (eNOS) and inducible NOS
(iNOS)) are expressed in various tissues and cells. NO plays
a vital role in diverse biological responses that include the
regulation of vascular tone, neurotransmission, anti-viral de-
fense and immune responses. Recent studies have also dem-
onstrated that NO is an important regulator of apoptosis.
Many lines of evidences suggest that NO may be involved
in the pathogenesis and associated tissue destruction of im-
mune disease. Enhanced NO production is observed in in£am-
matory arthritis (in£ammatory synovium and cartilage) and
the onset of arthritis in rodent models can be successfully
blocked by a NOS inhibitor [9,10]. The presence of activated
macrophages expressing high levels of iNOS and peroxynitrite
formation have been demonstrated in brain tissue from pa-
tients with multiple sclerosis [11]. Moreover, increased nNOS
expression has been detected in the cerebral cortex and spinal
cord during the development of experimental allergic encepha-
lomyelitis in Lewis rats [12]. On the other hand, an anti-apop-
totic role of NO in cultured cells has been demonstrated. NO
induces resistance to TNFK-induced hepatotoxicity [13], in-
hibits Fas-induced apoptosis in B Lymphocytes [14] and mod-
ulates CD95-induced apoptosis in T Lymphocytes [15].
NO has important functional e¡ects in the cardiovascular
system. It regulates vascular tone, protects endothelium from
vascular injury, inhibits platelet aggregation and modulates
adhesion of in£ammatory cells [16,17]. Thus it has anti-in-
£ammatory and anti-atherogenesis e¡ects. However, excessive
NO production induced by cytokines is also implicated in the
tissue injury of in£ammatory disease. Both the cytoprotective
and cytotoxic actions of NO are relevant to the pathogenesis
of vascular disease and the anti-in£ammatory/anti-atherogen-
esis and pro-in£ammatory/pro-atherogenesis actions of NO
may be mediated by its e¡ects on endothelial cell apoptosis.
The present study was designed to explore the e¡ect of NO on
human endothelial cell apoptosis.
2. Materials and methods
2.1. Cell extraction and culture
Human venous endothelial cells (HUVEC) were extracted from
umbilical veins. The cells were cultured in DMEM with 20% foetal
calf serum (15 mM HEPES, 2.8 mg/ml sodium bicarbonate, 2 mM L-
glutamine, 5 U/ml heparin, 20 Wg/ml endothelial cell growth factor
(ECGF), 100 Wg/ml penicillin) and apoptosis of the cells assessed
under di¡erent conditions.
2.2. Cell viability assay
Cell viability was determined using CellTiter 96AQueous One Sol-
ution Cell Proliferation Assay Kit (Promega, Madison, WI). HUVEC
grown in a 96-well plate were incubated with and without apoptotic
FEBS 20606 14-8-98 Cyaan Magenta Geel Zwart
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 0 8 4 4 - 8
*Corresponding author. Fax: (61) (2) 9382 4826.
E-mail: x.l.wang@unsw.edu.au
Abbreviations: NO, nitric oxide; TNFK, tumour necrosis factor alpha;
SNAP, S-nitroso-N-acetylpenicillamine; NOS, nitric oxide synthase;
HUVEC, human venous endothelial cells ; ECGF, endothelial cell
growth factor; ODQ, guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazo-
lo[4,3-a]quinoxalin-1-one; LDH, lactate dehydrogenase
FEBS 20606 FEBS Letters 433 (1998) 125^131
stimuli, followed by incubation with [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt;
MTS*] for 4 h at 37‡C. The amount of converted formadan by viable
cells was determined by measuring absorbance at 490 nm using a 96-
well plate reader photometer.
2.3. Cytotoxic assay (lactate dehydrogenase activity, LDH assay)
Cytotoxicity of endothelial cells was assessed using the CytoTox
96Cytotoxicity Assay System (Promega). The HUVEC were incubated
with and without apoptotic stimuli. Cells were lysed with lysis solu-
tion (1% Triton X-100, PBS) at 37‡C for 45 min followed by centrif-
ugation at 250Ug for 4 min. The supernatant was incubated with
assay bu¡er and substrate mix (diaphorase, lactate and NAD mix)
at room temperature for 30 min. The lactate dehydrogenase activity in
the supernatant was determined by measuring the absorbance at 490
nm using a 96-well plate reader photometer.
2.4. Apoptosis assay (DNA fragmentation detection)
DNA fragmentation was detected using the KLENOW FrgEL
DNA fragmentation detection kit (Calbiochem, San Diego, CA).
Brie£y, apoptotic endothelial cells (£oating and adherent) were har-
vested, ¢xed with 4% formaldehyde and applied on to glass slides.
Fixed cells were permeabilised with 0.04% Triton in TBS and endog-
enous peroxidase was inactivated by 3% H2O2 in methanol. Apoptosis
was detected by labeling the 3P-OH ends of fragmented DNA with
biotin-dNTP using klenow at 37‡C for 1 h. The slides were then
incubated with streptavidin horseradish peroxidase conjugate, fol-
lowed by incubation with 3,3P-diaminobenzidine and H2O2. Apoptotic
cells were identi¢ed by their dark brown nuclei seen under a light
microscope. The degree of apoptosis was determined by the percent-
age of apoptotic cells over total cells.
3. Results
3.1. NO inhibits TNFK-induced apoptosis
To assess whether NO has an anti-apoptotic e¡ect in endo-
thelial cells, TNFK was used to induce apoptosis as it has
been shown to trigger apoptosis in many cell lines including
endothelial cells. TNFK induced apoptosis in the HUVEC in a
dose-dependent fashion (data not shown). To determine
whether NO could prevent this TNFK-induced apoptosis,
the HUVEC were treated with TNFK together with the NO
donor SNAP. SNAP substantially delayed the onset and re-
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Fig. 1. Dose response of SNAP inhibition of TNFK-induced apop-
tosis. HUVEC were treated with 25 ng/ml of TNFK in the absence
or presence of increasing concentrations of SNAP for 24 h and the
apoptosis was determined as described in Section 2.
Fig. 2. cGMP pathway dependence of NO anti-apoptotic e¡ect. A:
Involvement of cGMP pathway in anti-apoptotic e¡ect in endothe-
lial cells. HUVEC were treated with 25 ng/ml TNFK, 10 WM
LY83583, or 25 ng/ml TNFK+10 WM LY83583 in the presence or
absence of 500 WM 8-bromo-cGMP. Apoptosis was determined by
detection of DNA fragmentation and cell viability. B: cGMP path-
way dependence of NO anti-apoptotic e¡ect. HUVEC were treated
with 25 ng/ml TNFK, 10 WM LY83583, or 25 ng/ml TNFK+10 WM
LY83583 in the presence or absence of 200 WM SNAP. Apoptosis
was determined by detection of DNA fragmentation and cell viabil-
ity.
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Fig. 3. Pro-apoptotic e¡ect of NO in endothelial cells. HUVEC were treated (A) with 750 WM SNAP or (B) without SNAP for 48 h and apop-
totic cells were identi¢ed by their dark brown nuclei (C) seen under a light microscope as described in Section 2.
Y.H. Shen et al./FEBS Letters 433 (1998) 125^131 127
duced the severity of TNFK-induced apoptosis. Within the
low concentration range (25^300 WM), SNAP inhibited
TNFK-induced apoptosis in a dose-dependent fashion with
maximum e¡ects (60%) at a concentration of 250 WM (Fig.
1). The anti-apoptotic e¡ects of SNAP was correlated with
inhibition of TNFK-induced decrease of cell viability and in-
crease of DNA fragmentation. However, higher concentra-
tions of SNAP (s 500 WM) increased the TNFK-induced
apoptosis. The concentrations of SNAP used (25^300 WM)
did not a¡ect cell viability in the absence of TNFK (data
not shown). These results suggest that low concentrations of
exogenous NO protect endothelial cells from TNFK-induced
apoptosis.
3.2. NO anti-apoptotic e¡ect is partially mediated through
cGMP pathway
The above observation indicates that NO is a potent inhib-
itor of apoptosis in endothelial cells. We next investigated the
mechanisms mediating the NO anti-apoptotic e¡ect in these
cells. The secondary messenger cGMP signaling pathway is a
major mediator of the physiological e¡ects of NO. NO has
been shown to prevent apoptosis via either cGMP-dependent
or cGMP-independent mechanisms in other cell lines [15,18].
To determine whether NO inhibits TNFK-induced endothelial
cell apoptosis through a cGMP pathway, we ¢rst investigated
the involvement of the cGMP pathway in anti-apoptotic ac-
tivity. The cGMP donor, 8-bromo-cGMP, inhibited TNFK-
induced apoptosis (Fig. 2A), but itself did not induce apop-
tosis. The guanylyl cyclase inhibitor LY83583 (10 WM) not
only induced apoptosis by itself, but also enhanced TNFK-
induced apoptosis. The apoptosis induced by LY83583, or
TNFK+LY 83583 could be inhibited by the addition of 8-
bromo-cGMP. Similar results were also obtained with another
guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxa-
lin-1-one (ODQ). These ¢ndings indicate that cGMP pathway
is involved in the anti-apoptosis activity in endothelial cells.
However, 8-bromo-cGMP did not completely abolished the
apoptosis induced by these TNFK or LY83583 indicating
that mechanisms other than that of the cGMP pathway may
be involved in the suppression of apoptosis in endothelial
cells.
Next, experiments were conducted to determine whether the
NO anti-apoptotic e¡ect is mediated via this cGMP pathway.
SNAP not only partially prevented LY83583-induced cell
death, but also decreased the LY83583 enhancement of
TNFK-induced apoptosis (Fig. 2B). These results indicate
that NO anti-apoptotic e¡ect is partially mediated via the
cGMP pathway. However, the ¢nding that 8-bromo-cGMP
inhibited TNFK-induced apoptosis to a lesser extent than
that of SNAP indicates that mechanisms other than cGMP
generation may also be involved in NO-mediated anti-apop-
totic e¡ects.
3.3. NO induces apoptosis in endothelial cells
Since NO has been reported to induce apoptosis in many
cell lines, we also assessed this in endothelial cells. The HU-
VEC were treated with a range concentrations of SNAP for
72 h. While low concentration (25^200 WM) of SNAP did not
a¡ect cell viability, high concentrations of SNAP induced en-
dothelial apoptosis as determined by the detection of apop-
totic cells (Fig. 3). The induction was dose-dependent with a
threshold concentration at 400 WM SNAP and complete in-
duction at 1 mM SNAP (Fig. 4A). The induction of apoptosis
by SNAP was a relatively slow process. It started after 48 h of
SNAP treatment, and peaked after day 5, when almost all the
cells lost viability (Fig. 4B). The pro-apoptotic e¡ects of
SNAP was correlated with decreased cell viability and in-
creased DNA fragmentation. There was no increased LDH
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Fig. 4. Dose response and time course of NO pro-apoptotic e¡ect
in endothelial cells. A: Dose response of NO-induced apoptosis.
HUVEC were treated with increasing concentrations of SNAP for
72 h and cell viability and apoptosis determined. B: Time course of
NO-induced apoptosis. HUVEC were treated with 500 WM of
SNAP for 1^5 days and the cell viability determined.
Y.H. Shen et al./FEBS Letters 433 (1998) 125^131128
release detectable after SNAP incubation for 48 h which ex-
cluded the induction of cell necrosis (data not shown). How-
ever, the NO e¡ect on endothelial cell apoptosis di¡ered
markedly depending upon the state of con£uence of the cells
in that apoptosis was more extensive in subcon£uent cells
than in con£uent cells (data not shown). These results indicate
that high concentrations of SNAP induces apoptosis in endo-
thelial cells.
3.4. NO induces apoptosis through cGMP-independent
pathways
To investigate the involvement of the cGMP pathway in
this high NO concentration-induced apoptosis, the HUVEC
were treated with SNAP in the absence or presence of 5 nM
LY83583 for 72 h. In the absence of LY83583, SNAP began
inducing apoptosis at 500 WM with maximum induction (60%
of control) occurring at 1 mM (Fig. 5). However, in the pres-
ence of LY83583, SNAP induced apoptosis at 200 WM with
complete induction at 1 mM. The apoptotic e¡ect of the com-
bined treatment of SNAP and LY83583 was stronger than a
simple addition of their individual e¡ects indicating that
LY83583, by blocking the cGMP pathway, enhanced
SNAP-induced apoptosis. Furthermore, 8-bromo-cGMP
alone did not induce apoptosis, even at high concentration
for up to 5 days (data not shown). These results indicate
that a high concentration of NO induces apoptosis via
cGMP-independent pathways and that the cGMP pathway
has a protective e¡ect in that it prevents high concentration
NO-induced apoptosis in endothelial cells.
4. Discussion
Apoptosis is a physiological process which contributes to
the control of cell population. However, excessive apoptosis
of endothelial cells may be pathological and promotes athero-
genesis. The results of this study indicate that, in endothelial
cells, low concentrations of NO inhibit TNFK-induced apop-
tosis but high concentrations of NO induce apoptosis. The
study also shows that the cGMP pathway is involved in the
anti-apoptotic action in endothelial cells and that the NO
anti-apoptotic e¡ect is partially mediated through this path-
way. However, high concentrations of NO induce endothelial
cell apoptosis through cGMP-independent pathways.
Opposing e¡ects of NO on apoptosis in other cells have
been reported and the role of NO in apoptosis appears to
be cell type speci¢c. Induction of apoptosis by NO has been
described in various cell lines [9,19^22], whilst other studies
have demonstrated inhibitory e¡ects [13^15,23,24]. In endo-
thelial cells, it has been shown that shear stress inhibits
TNFK- or oxidative stress-induced apoptosis and that NO is
involved in the anti-apoptotic e¡ect of shear stress [25]. More-
over, NO produced in iNOS transfected endothelial cells in-
hibited lipopolysaccharide-induced apoptosis and it was sug-
gested that iNOS gene transfer may promote endothelial
regeneration and accelerate vascular healing [26]. In the
present study, we show that NO has both anti-apoptotic
and pro-apoptotic e¡ects in endothelial cells and that this
depends on the NO concentration; low concentration of NO
inhibits TNFK-induced apoptosis, high concentration of NO
induces apoptosis. Thus, a constant, basal level of NO, pro-
duced under physiological conditions, may protect endothelial
cells from internal and external destructive factors through
anti-apoptotic e¡ects whereas a high level of NO, released
under pathological conditions (e.g. in bacterial infection and
in£ammatory disease), may be cytotoxic to endothelium.
The mechanisms mediating the NO anti-apoptotic actions
in endothelial cells have not been well de¢ned. The cGMP-
dependent pathway has been demonstrated to be involved in
NO-mediated inhibition of apoptosis in eosinophils [27], T
lymphocytes [15] and hepatocytes [18]. However, the cGMP
dependence of the NO anti-apoptotic e¡ect seems to be cell
type-speci¢c. It has been reported that basal NOS activity in
human leukocytes inhibits Fas-induced apoptosis via a
cGMP-independent mechanism [14]. The involvement of
cGMP in endothelial cell apoptosis has not been explored.
Here we demonstrated that the cGMP-dependent pathway
has anti-apoptotic activity in endothelial cells and that the
NO anti-apoptotic e¡ect is partially mediated by this path-
way. Activation of caspase proteases has been shown to be
associated with phosphorylation/dephosphorylation of up-
stream signaling [28]. Thus, cGMP generation may activate
cGMP-dependent protein kinase which could in turn regulate
the activities of apoptotic signal transducers (e.g. members of
the caspase family or members of the Bcl-2 family) by direct
or indirect modulating protein phosphorylation events.
Although it has been demonstrated that NO/cGMP action
is su⁄cient for inhibition of the CD95 signaling cascade and
protection from apoptosis in T lymphocytes [15], the failure of
either NO or cGMP to completely suppress TNFK-induced
apoptosis indicates that mechanisms other than NO/cGMP
pathway may be responsible for the down regulation of apop-
tosis signaling in endothelial cells. In addition, the fact that
the protective e¡ect of SNAP is stronger than that of 8-bro-
mo-cGMP suggests that mechanisms other than the cGMP
pathway may also contribute to NO-mediated anti-apoptosis
e¡ect in endothelial cells. NO can react with oxygen radicals
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Fig. 5. Enhancement of LY83583 on SNAP-induced apoptosis. HU-
VEC were treated with increasing concentrations of SNAP in the
presence or absence of 5 WM of LY83583 for 72 h and cell viability
determined.
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thereby in£uence the redox balance. In hepatic cells, SNAP
transiently changes the intracellular redox state by inducing
glutathione oxidation and the formation of S-nitrosogluta-
thione and NO protected cells from TNF+actinomycin D-in-
duced apoptosis through this glutathione oxidation [13]. In
addition, NO may also interfere with haem proteins and en-
zymes containing iron-sulphur clusters, or modulate enzyme
activity by S-nitrosylation of the proteins. Direct S-nitrosyla-
tion of caspases by NO may be one mechanism mediating the
NO-induced anti-apoptotic e¡ect. It has been shown that ex-
posure of puri¢ed recombinant caspase-3 to an NO or NO
donor directly inhibited caspase-3-like activity through pro-
tein S-nitrosylation [18].
The molecular mechanisms underlying the NO pro-apop-
totic e¡ect are unclear. Our ¢nding that cGMP did not induce
apoptosis even after prolonged high concentration treatment
establishes that NO induces endothelial apoptosis via cGMP-
independent pathways. Also, SNAP induced stronger apopto-
sis in the presence of LY83583 indicating that the cGMP
pathway may protect endothelial cells from NO-induced
apoptosis. Mechanisms for high dose NO-induced apoptosis
remain speculative. NO reacts rapidly with superoxide to form
the highly toxic peroxynitrite (ONOO3), and it has been dem-
onstrated that both NO and ONOO3 can damage DNA di-
rectly [29^36]. This could trigger the p53-dependent or p53-
independent apoptotic cell death pathways [36,37], with sub-
sequent activation of caspases or related proteases, and cleav-
age of poly(ADP-ribose) polymerase [22].
Many factors may determine whether endothelial cells
undergo apoptosis when exposed to NO. These include the
amounts of NO being produced, the di¡erent redox states
of NO, and the local environment that may promote further
production of cytotoxic moieties such as peroxynitrite. It has
been shown that the interaction of NO with enzymes possess-
ing the haem group, the iron-sulphur cluster, or thiol groups
depends on its redox state [38,39] and that NO can exhibit
cytoprotective or cytotoxic e¡ects depending on the chemistry
it undergoes in a given biological milieu [38^40]. The opposing
e¡ects of NO on endothelial apoptosis may also depend on
the availability of anti-apoptotic signaling transducers (such
as the cGMP pathway and members of Bcl-2 family) and pro-
apoptotic signaling transducers (such as caspases and ICE
family members). Thus, the end result may depend on the
balance between a number of anti-apoptotic and pro-apop-
totic factors.
In summary, the evidence reported here demonstrates both
an anti-apoptotic e¡ect of low concentration of NO and a
pro-apoptotic e¡ect of high concentration of NO in endothe-
lial cells. The NO anti-apoptotic e¡ect is partially mediated
through the cGMP pathway, while the NO pro-apoptotic ef-
fect is cGMP-independent and the cGMP pathway has a pro-
tective e¡ect from NO-induced endothelial apoptosis. This
double-edged e¡ect of NO may have signi¢cant implications
for the initiation and progression of atherosclerosis.
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